| Dr Jean Bachar, MD | |
|
120 Eagle Rock Ave Ste 154, East Hanover, NJ 07936-3168 | |
| (201) 447-4772 | |
| (862) 701-6444 |
| Full Name | Dr Jean Bachar |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 17 Years |
| Location | 120 Eagle Rock Ave Ste 154, East Hanover, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437318334 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 60260473 (New York) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | 25MA09681600 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rehabilitation Specialists Of New Jersey Llc | 9931197050 | 8 |
News Archive
Data published in the March issue of the Annals of Surgery show that investigational use of sacral nerve stimulation with Medtronic InterStim® Therapy reduces fecal incontinent episodes and increases quality of life in patients with the condition. The 120-patient, multi-center study - the largest trial of its kind in the world and the first such trial in North America - examined the efficacy of InterStim Therapy in patients with chronic fecal incontinence who had failed or were not candidates for more conservative treatments.
Concerns over possible radiation effects of CT scans detailed in a report yesterday in the New England Journal of Medicine should not scare people away from getting medically needed CT scans, as the scans play a critical role in saving the lives of thousands of people every day, according to an official with the American Association of Physicists in Medicine (AAPM).
Human Genome Sciences, Inc. and GlaxoSmithKline PLC (GSK) today announced the full presentation of results from BLISS-52, the first of two pivotal Phase 3 trials of BENLYSTA™ (belimumab) in seropositive patients with systemic lupus erythematosus (SLE).
Two multinational clinical studies indicate that the RDI's system for predicting how HIV and AIDS patients will respond to different drugs could be a useful tool with potential clinical and economic benefits. The studies, published in the January issue of AIDS Patient Care and STDs, involved highly experienced physicians in the USA, Canada and Italy who used the system to help them select the optimum combination of HIV drugs for patients whose therapy was failing.
› Verified 7 days ago
| Entity Name | Rehabilitation Specialists Of New Jersey Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790727220 PECOS PAC ID: 9931197050 Enrollment ID: O20040505001260 |
News Archive
Data published in the March issue of the Annals of Surgery show that investigational use of sacral nerve stimulation with Medtronic InterStim® Therapy reduces fecal incontinent episodes and increases quality of life in patients with the condition. The 120-patient, multi-center study - the largest trial of its kind in the world and the first such trial in North America - examined the efficacy of InterStim Therapy in patients with chronic fecal incontinence who had failed or were not candidates for more conservative treatments.
Concerns over possible radiation effects of CT scans detailed in a report yesterday in the New England Journal of Medicine should not scare people away from getting medically needed CT scans, as the scans play a critical role in saving the lives of thousands of people every day, according to an official with the American Association of Physicists in Medicine (AAPM).
Human Genome Sciences, Inc. and GlaxoSmithKline PLC (GSK) today announced the full presentation of results from BLISS-52, the first of two pivotal Phase 3 trials of BENLYSTA™ (belimumab) in seropositive patients with systemic lupus erythematosus (SLE).
Two multinational clinical studies indicate that the RDI's system for predicting how HIV and AIDS patients will respond to different drugs could be a useful tool with potential clinical and economic benefits. The studies, published in the January issue of AIDS Patient Care and STDs, involved highly experienced physicians in the USA, Canada and Italy who used the system to help them select the optimum combination of HIV drugs for patients whose therapy was failing.
› Verified 7 days ago
| Entity Name | Practice Associates Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427016385 PECOS PAC ID: 5890703177 Enrollment ID: O20060330000690 |
News Archive
Data published in the March issue of the Annals of Surgery show that investigational use of sacral nerve stimulation with Medtronic InterStim® Therapy reduces fecal incontinent episodes and increases quality of life in patients with the condition. The 120-patient, multi-center study - the largest trial of its kind in the world and the first such trial in North America - examined the efficacy of InterStim Therapy in patients with chronic fecal incontinence who had failed or were not candidates for more conservative treatments.
Concerns over possible radiation effects of CT scans detailed in a report yesterday in the New England Journal of Medicine should not scare people away from getting medically needed CT scans, as the scans play a critical role in saving the lives of thousands of people every day, according to an official with the American Association of Physicists in Medicine (AAPM).
Human Genome Sciences, Inc. and GlaxoSmithKline PLC (GSK) today announced the full presentation of results from BLISS-52, the first of two pivotal Phase 3 trials of BENLYSTA™ (belimumab) in seropositive patients with systemic lupus erythematosus (SLE).
Two multinational clinical studies indicate that the RDI's system for predicting how HIV and AIDS patients will respond to different drugs could be a useful tool with potential clinical and economic benefits. The studies, published in the January issue of AIDS Patient Care and STDs, involved highly experienced physicians in the USA, Canada and Italy who used the system to help them select the optimum combination of HIV drugs for patients whose therapy was failing.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jean Bachar, MD 120 Eagle Rock Ave Ste 154, East Hanover, NJ 07936-3168 Ph: (201) 447-4772 | Dr Jean Bachar, MD 120 Eagle Rock Ave Ste 154, East Hanover, NJ 07936-3168 Ph: (201) 447-4772 |
News Archive
Data published in the March issue of the Annals of Surgery show that investigational use of sacral nerve stimulation with Medtronic InterStim® Therapy reduces fecal incontinent episodes and increases quality of life in patients with the condition. The 120-patient, multi-center study - the largest trial of its kind in the world and the first such trial in North America - examined the efficacy of InterStim Therapy in patients with chronic fecal incontinence who had failed or were not candidates for more conservative treatments.
Concerns over possible radiation effects of CT scans detailed in a report yesterday in the New England Journal of Medicine should not scare people away from getting medically needed CT scans, as the scans play a critical role in saving the lives of thousands of people every day, according to an official with the American Association of Physicists in Medicine (AAPM).
Human Genome Sciences, Inc. and GlaxoSmithKline PLC (GSK) today announced the full presentation of results from BLISS-52, the first of two pivotal Phase 3 trials of BENLYSTA™ (belimumab) in seropositive patients with systemic lupus erythematosus (SLE).
Two multinational clinical studies indicate that the RDI's system for predicting how HIV and AIDS patients will respond to different drugs could be a useful tool with potential clinical and economic benefits. The studies, published in the January issue of AIDS Patient Care and STDs, involved highly experienced physicians in the USA, Canada and Italy who used the system to help them select the optimum combination of HIV drugs for patients whose therapy was failing.
› Verified 7 days ago
Sarah Gaballah, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 120 Eagle Rock Ave, Ste 154, East Hanover, NJ 07936 Phone: 201-447-4772 Fax: 862-701-6444 | |
Amanda Ansley Kelly, Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 120 Eagle Rock Ave Ste 154, East Hanover, NJ 07936 Phone: 120-144-7477 | |
Dr. Cristin Mckenna, M.D., PH.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 120 Eagle Rock Ave Ste 154, East Hanover, NJ 07936 Phone: 201-447-4772 Fax: 973-243-6861 | |
Dr. Julie T Lin, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 120 Eagle Rock Ave, Suite 154, East Hanover, NJ 07936 Phone: 201-447-4772 | |
James D Girardy, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 120 Eagle Rock Ave, Suite 154, East Hanover, NJ 07936 Phone: 201-407-5145 Fax: 862-701-6444 | |
Patrick Kortebein, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1 Health Plz, East Hanover, NJ 07936 Phone: 862-778-9800 |